Ligand validation:4HJ1

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4HJ1_MES_B_1205	67%	17%	0.113	0.92	2.14	1.45	1	1	0	0	100%	1
4HJ1_MES_C_1207	60%	1%	0.146	0.93	2.45	5.06	1	5	0	0	100%	0.7
4HJ1_MES_D_1207	50%	1%	0.139	0.889	2.45	5.7	1	9	0	0	100%	1
4HJ1_MES_A_1206	46%	1%	0.159	0.893	2.31	6	1	8	1	0	100%	0.7
4HJ1_MES_D_1208	19%	1%	0.207	0.803	2.19	6.06	1	5	3	0	100%	0.7
6EGT_MES_C_1304	30%	9%	0.234	0.896	2.28	2.16	1	6	0	0	100%	0.74
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
5A0C_MES_B_1002	100%	11%	0.033	0.993	1.84	2.39	3	3	0	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
5APG_MES_A_1187	100%	12%	0.044	0.99	1.48	2.57	3	6	0	0	100%	0.9292

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.